





19th CardioVascular Summit: TCTAP 2014Case Summary:
EVT was conducted for penile gangrene.
EVT was performed for inferior gluteal artery and internal illiac artery.
The day after EVT, life-threatening pain of penis was resolved. Six months after the
procedure complete wound healing was achieved.
This case illustrates successful endovascular therapy in a case of penile gangrene with
intractable pain.
TCTAP C-214
Intraluminal Angioplasty in Complex Iliac and Superﬁcial Femoral Arterial,
Chronic Total Occlusive (CTO) Lesions Using Astato Guidewire
Sang-Ho Park
Soon Chun Hyang University Cheonan Hospital, Korea (Republic of)
[Clinical Information]
Patient initials or identiﬁer number:
JHC
Relevant clinical history and physical exam:
A 78 year-old woman was transferred from local hospital She had the history of
myocardial infarction, smoking, and chronic obstructive pulmonary disease. She
suffered left foot pain several month ago and recently local hospital due to gangrenous
change on left 2nd toe (Ruthorford category 5-6) about 3 weeks ago. Her vital sign was
110/70 mmHg in blood pressure, 110 beat per minute in pulse rate. The ﬁne wheezing
were auscultated in both lung ﬁelds.
Relevant test results prior to catheterization:
Chest X-ray showed inﬂated lung and increased AP diameter of lung. ECG demon-
strated atrial ﬁbrillation. In the laboratory ﬁndings, NT-pro-BNP was elevated into
2516 pg/ml and CRP 145 mg/L. BUN/Cr was within normal limit. Echocardiogram
showed that LVEF was approximately 35%, inferoposterior wall with thinning was
akinesia, moderate both atrial enlargement, and moderate resting pulmonary hyper-
tention (pressure gradient between right atrium and right ventricle, 50mmHg). Left
side ankle-brachial index was unmeasurable. Extremity angioCT showed left external
iliac artery (EIA) from EIA ostium to common femoral artery (CFA) and left SFA
from mid-portion to popliteal P1 zone were totally occluded (Fig. 1). Also, left
posterior tibial artery and peroneal artery were totally occluded. Bypass surgery could
not be performed due to COPD and depressed LVEF with RWMA of LV. So,
endovascular therapy for iliac and SFA lesion was planned.
Relevant catheterization ﬁndings:
Right femoral artery puncture with 6F short sheath was done. Using 5F Omni catheter,
035 terumo guidewire was advanced in front of the CTO of EIA. Cine angiography
showed stumpless CTO of EIA with collaterals from IEA to CFA.
[Interventional Management]
Procedural step:
Retrograde guidewire tracking was planned because of stumpless lesion of EIA. Next,
left femoral artery was punctured and 6Fr short sheath was inserted. 014 miracle 3g
guidewire was selected to track into CTO lesion, supported by straight CXI micro-
catheter. Step by step, miracle 3g guidewire and CXI microcatheter was advanced into
re-entry portion of EIA ostium. However, That didn’t penestrate the CTO cap of EIA
and re-enter. At this times, miracle 3g guidewire was changed into astato 30g
guidewire (ASAHI) and successfully penestrated the CTO cap of EIA and re-entered
into true lumen of CIA. Astato 30g guidewire was externalized into Contralateral
guiding sheath and was changed into 014 runthrough guidewire through CXIJACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/CASmicrocatheter. Next, ballooning with sleek 3.5x150mm was done upto maximal
pressure (15atm) during 120 seconds. And then, 014 Runthrough guidewire was
changed into 1.5 j-tip 035 terumo guidewire. After ballooning with Sleek 3.5x150mm,
residual stenosis was approximately 50-55% and there was luminal hazziness at
ballooned CTO lesion. So, stent deployment with SMART 8.0x120mm was done
without immediate complication. After stent deployment, residual stenosis was less
than 30% and pressure gradient was less than 10mmHg.
Continuously, Contralateral-1 guiding sheath went down and was positioned at mid-
SFA portion in front of CTO lesion of SFA. At this situation, the sheath inserted at left
femoral artery didn’t box in the Contralateral-1 guiding sheath. In the state of road-
map, Astato 30g guidewire supported by CXI microcatheter tried to pass through CTO
lesion. However, the multiple attempt for astato 30g guidewire to pass into target
lesion was failed and ﬁstula from femoral artery to vein was complicated. As next
step, using dorsal artery route, retrograde approach was planned. Micro-needle was
successfully punctured through dorsal artery. And then, the micro-guidewire and
sheath were inserted (Fig. 2A). After then, the guidewire of micro-puncture set was
changed into 014 Runthrough guidewire. As wiring of iliac lesion, step by step,
guidewire and CXI microcatheter slowly advanced through SFA CTO lesion, How-
ever, Miracle 3g guidewire didn’t penetrate the CTO lesion of SFA. So, as before,
miracle 3g guidewire was changed into Astato 30g guidewire and successfully
penestrated the CTO cap of SFA and re-entered into true lumen of SFA (Fig. 2B, 2C).
Astato 30g guidewire was externalized into Contralateral guiding sheath and was
changed into 014 Runthrough guidewire through CXI microcatheter. And then,
ballooning with sleek 3.5x150mm was done upto maximal pressure (15atm) during
120 seconds (Fig. 3). 014 Runthrough guidewire was changed into 1.5 j-tip 035
terumo guidewire. After ballooning, residual stenosis was approximately 50-55% and
there was luminal hazziness at ballooned CTO lesion. So, stent deployment with
SMART 6.0x150mm was done without immediate complication. After stent
deployment, residual stenosis was approximately 50-55%. Adjuvant ballooning with
Powerﬂex 4.0x100mm was done upto maximal pressure during 30 second 2 times.
Finally, successful procedure was achieved (Fig. 3). After procedure, ABI was
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Endovascular Treatment of Type 2 Endoleak After EVAR for Aortocaval Fistula
Herman Schroë
Ziekenhuis Oost Limburg, Belgium
[Clinical Information]
Patient initials or identiﬁer number:
hs case 1 / tctapic001
Relevant clinical history and physical exam:
In July 2013, a 67-year old male was presented at the emergency department with the
triad of an abdominal continuous bruit, a pulsatile abdominal mass and severe
congestive heart failure. CT-scan revealed a ruptured infrarenal aortic aneurysm into
the inferior vena cava. This was treated with a aorto-bi-iliac stentgraft. On the ﬁnal
angiogram at the end of this procedure, there was no evidence of an important
endoleak. Nine days later, the patient left the hospital in good condition.
In November 2013, a ﬁrst follow-up CT-scan was performed and this showed an
important type II endoleak sustained by a patent inferior mesenteric artery and a
persistent aortocaval communication. The aneurysm diameter was reduced, but it was
deemed necessary to treat the aortocaval ﬁstula. Therefore, a transvenous embolization
of the aneurysmal sac was performed with glue and coils. The day after the procedure
however, a new CT-scan was performed, and this showed a persisting endoleak
through inferior mesenteric artery and the aortocaval ﬁstula. The next day, a new
successfull embolization of the inferior mesenteric artery was performed through a
translumbar puncture.
Relevant test results prior to catheterization:
Clinical examination and CT scan on admission.
CT scan on follow up
Relevant catheterization ﬁndings:
Bilateral access: 5F (right) and 11F (left) sheath in common femoral vein
5F cobra catheter through 5F sheath and positioning into the aneurysm sac through the
aortocaval ﬁstula
Contrast injection through cobra catheter shows a large communication between
aneurysm sac and inferior vena cava
Contrast injection through the right sheath shows a leak of contrast from the inferior
vena cava into the aneurysm sac
[Interventional Management]
Procedural step:
Balloon (20mm diameter-40 mm) through 11F sheath and positioning into inferior
vena cava, at the level of the ﬁstula
Insufﬂation of the balloon: temporary occlusion of inferior vena cava and aortocaval
ﬁstula
Placement of coaxial microcatheter through the cobra catheter into the aneurysm sac
Embolization with several wire coils and injection of Lipiodol  – Histoacryl 
mixture into the aneurysm sac
Escape of some embolic agent into the inferior vena cava: to retain this, placement of a
Wall stent (24mm-70mm) at the level of the aortocaval ﬁstula into IVC is performed
Postdilatation of the stent with the 20mm balloon
Contrast injection shows good patency of the inferior vena cava and entrapment of
embolic agent between the wall of the inferior vena cava and the Wall stent.
End of procedure
CT scan one day later shows persistent type II endoleak, sustained by patent AMI with
outﬂow through patent lumbar arteries and median sacral artery, and a persistent
aortocaval ﬁstula
New procedure under general anesthesia and ventral decubitus
Translumbar puncture of the endoleak cavity with 18G needle
Contrast injection shows persistent endoleak with inﬂow from the inferior mesenteric
artery and outﬂow through aortocaval ﬁstula
Advancement of microcatheter (Progreat 2,7) into the inferior mesenteric artery
Obliteration of inferior mesenteric artery by placing several microcoils
Additional injection of Lipiodol-Histoacryl mixture into the aneurysm sac until it
is completely obliteratedS198 JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP AbstractTCTAP C-216
Successful Endovascular Intervention of Chronic Total Occlusion with Severe
Calciﬁcation in the Superﬁcial Femoral Artery Using 0.035 Inch Wire Terminal
End
Ryuta Sugihara, Koshi Matsuo
Osaka Police Hospital, Japan
[Clinical Information]
Patient initials or identiﬁer number:
R.T 01860676
Relevant clinical history and physical exam:
An 85-year-old female had previously received femoral-femoral bypass (F-F bypass)
surgery for left common internal artery occlusion, and femoral-popliteal artery bypass
(F-P bypass) surgery for left superﬁcial femoral artery (SFA) occlusion.
She admitted for left toe pain which showed cyanosis and gangrenous change. Duplex
showed F-P bypass was occluded. Therefore, we decided to perform endovascular
therapy for left superﬁcial femoral artery.s/CASE/Peripheral Vascular Intervention (Non-carotid, Non-neurovascular)
